Significance: Government authorities, including in the United States, are speeding up licensing for clinical trials of these controlled drugs. Substantial philanthropic funding supports psychedelic medicine and campaigns for regulated use of these drugs, including for treatment of PTSD, chronic depression and addiction. Impacts: Biotechnology companies expect psychedelic therapies to become...